Recovery includes managing pain, following post-operative care instructions, and undergoing rehabilitation for speech and swallowing if needed. Follow-up visits are crucial for monitoring progress.

Enhanced External Counterpulsation (EECP) therapy is a non-invasive treatment that helps improve blood flow to the heart and relieve symptoms of angina and heart failure.

EECP therapy uses inflatable cuffs wrapped around the legs to compress and decompress the blood vessels, promoting increased blood flow to the heart during the relaxation phase of the heartbeat.

Patients with chronic stable angina, heart failure, or those who are not suitable candidates for invasive procedures like angioplasty or bypass surgery may benefit from EECP therapy.

EECP therapy can help reduce angina symptoms, improve exercise tolerance, enhance the quality of life, and decrease the need for medication in some patients.

Each EECP session typically lasts about one hour and is usually conducted five days a week for a total of seven weeks.

A positive result indicates past infection with the Dengue virus or successful vaccination against Dengue.

No, additional tests, such as Dengue IgM or PCR, may be required to differentiate recent infections from past ones.

No, the Dengue IgG test is not suitable for diagnosing acute Dengue infection. IgG antibodies appear later in the course of infection.

Dengue IgG antibodies can remain detectable in the bloodstream for months to years after infection or vaccination.

A negative result suggests no detectable Dengue IgG antibodies. If symptoms persist or there is a recent exposure, consult a healthcare provider for further evaluation.